Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
82 hedge funds and large institutions have $185M invested in Taro Pharmaceutical Industries Ltd. in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 9 closing their positions.
122% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 9
15% more funds holding
Funds holding: 71 → 82 (+11)
0% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 23
1% less capital invested
Capital invested by funds: $186M → $185M (-$1.41M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$9.95M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.78M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.66M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$2.54M |
| 5 |
Morgan Stanley
New York
|
+$1.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$9.32M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$8.48M |
| 3 |
D.E. Shaw & Co
New York
|
-$904K |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$903K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$395K |
TARO Hedge Fund Activity: Q3 2023 in Review
82 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2023, worth a combined $185M — down 0.76% from $186M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new TARO positions and 9 closed out — a net gain of 11 holders — while 23 added to existing stakes and 23 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $9.95M. The largest seller was Acadian Asset Management, cutting an estimated $9.32M.
- 82 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2023, up from 71 in Q2 2023.
- Funds reported $185M of Taro Pharmaceutical Industries Ltd. stock for Q3 2023, down 0.76% quarter-over-quarter.
- 20 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2023 and 9 closed out, a net change of +11 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2023 was Invesco, an estimated $9.95M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2023 was Acadian Asset Management, an estimated $9.32M sold.
Based on aggregated 13F filings for Q3 2023.